3 active not recruiting, 2 completed. 4 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Active not recruiting 2, Completed 2 |
| Phase 3 | 2 | Active not recruiting 1, Completed 1 |
| Phase 1 | 1 | Active not recruiting 1 |
Follow Metastatic Malignant Neoplasm in the Lymph Nodes: new trials by email Literature Review of Metastatic Malignant Neoplasm in the Lymph Nodes trials Research Report on Metastatic Malignant Neoplasm in the Lymph Nodes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study Cisplatin, Intensity-Modulated Proton Therapy, Quality-of-Life Assessment - Head and Neck Carcinoma, Head and Neck Carcinoma of Unknown Primary | Phase 2 | Active not recruiting | Mayo Clinic | 174 | 2022-02-16 | 2026-07-16 |
| Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy Avelumab, Biospecimen Collection, Bone Scan - Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Malignant Neoplasm in the Bone | Phase 1 / Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 90 | 2020-10-14 | 2026-10-07 |
| Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer Hypofractionated Radiation Therapy, Intensity-Modulated Radiation Therapy, Metastasectomy - Recurrent Prostate Carcinoma, Metastatic Malignant Neoplasm in the Bone | Phase 2 | Completed | University of Utah | 20 | 2019-09-09 | 2026-07-22 |
| Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study Biospecimen Collection, Bone Scan, Cabozantinib - Clear Cell Renal Cell Carcinoma, Metastatic Malignant Neoplasm in the Bone | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 1175 | 2019-06-07 | 2026-10-26 |
| Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival Stereotactic Body Radiotherapy, Surgery - Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8, Metastatic Breast Carcinoma | Phase 2 / Phase 3 | Completed | NRG Oncology | 129 | 2014-12-24 | 2026-07-10 |
Lymphatic Metastasis (5) · Prostatic Neoplasms (2) · Breast Neoplasms (1) · Carcinoma, Renal Cell (1) · Hypopharyngeal Neoplasms (1) · Laryngeal Neoplasms (1) · Mouth Neoplasms (1) · Oropharyngeal Neoplasms (1) · Paranasal Sinus Neoplasms (1) · Salivary Gland Neoplasms (1)
Neoplasm Metastasis (5) · Neoplasms (5) · Neoplasms by Site (5) · Neoplastic Processes (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Male Urogenital Diseases (3) · Urogenital Diseases (3) · Urogenital Neoplasms (3) · Genital Diseases (2) · Genital Diseases, Male (2) · Genital Neoplasms, Male (2) · Prostatic Diseases (2) · Adenocarcinoma (1) · Breast Diseases (1)
Magnetic Resonance Spectroscopy (3) · Specimen Handling (3) · Radiosurgery (2) · Radiotherapy, Intensity-Modulated (2) · 1,2-diaminocyclohexaneplatinum II citrate (1) · CTLA-4 Antigen (1) · Cisplatin (1) · Ipilimumab (1) · Metastasectomy (1) · Nivolumab (1) · Platinum (1) · Radiation Dose Hypofractionation (1) · Surgical Procedures, Operative (1) · X-Rays (1) · avelumab (1)
National Cancer Institute (NCI) (2) · Mayo Clinic (1) · NRG Oncology (1) · University of Utah (1)
United States (5) · Canada (1) · Puerto Rico (1) · Saudi Arabia (1) · South Korea (1)
Alejandro Sanchez (1) · Russell K Pachynski (1) · Scott C. Lester, M.D. (1) · Steven J Chmura (1) · Tian Zhang (1)
PMID 35304832, PMID 35383907, PMID 35602670
U10CA180821 (1), U10CA180868 (1), UM1CA186689 (1), UM1CA186704 (1)